MainPointe Pharma acquires several Mission Pharmacal OTCs
Mission Pharmacal on Wednesday divested several consumer products to MainPointe Pharmaceuticals along with the marketing rights of additional consumer products that have been licensed by Mission to MainPointe. As part of these transactions, the companies have also entered into a renewable contract manufacturing agreement to continue manufacturing all of the included products that are currently made in Mission’s manufacturing facility.
“These are exciting agreements that will provide consumers greater access to the products involved due to MainPointe’s existing relationships within more diverse distribution channels,” Neill Walsdorf, Jr., Mission president, said. “Mission remains passionate about the products involved, and more importantly, we are steadfast in our support of the end users who rely on these products every day.”
As part of the agreements, the Thera-Gesic, Thera-Gesic Plus, Dr. Smith’s Diaper Rash Ointment, Dr. Smith’s Diaper Rash Spray, Dr. Smith’s Adult Barrier Spray and Dr. Smith’s Adult Ointment have been divested.
In addition, marketing rights have been licensed by Mission to MainPointe for the following Calcet, Fosfree, Heat Guard, Maxilube and Lycelle Head Lice Removal Kit.
“We look at these agreements as the beginning of an exciting strategic partnership between Mission and MainPointe,” Walsdorf said. “Our industry is continually evolving and we hold strong to the belief that partnering for success is more essential today than ever before.”
The new portfolio of products joins Nexafed and Nexafed Sinus as core MainPointe Pharmaceuticals OTC products being supplied by the manufacturer. This past fall, MainPointe acquired the rights to these popular diversion-resistant cough/cold products from Acura Pharmaceuticals.
As part of that deal, MainPointe brought Nexafed 2.0 to market late last year.
“Conversion of pseudoephedrine products into methamphetamine remains an acute problem in many communities,” John Schutte, MainPointe chairman and CEO, said when MainPoint first acquired the rights to market Nexafed. “The Nexafed products have proven to be a success in curbing this costly problem and we look forward to driving this business forward.”
Walgreens: As West recovers, flu incidence gains in Northeast
While flu incidence appears to recede in the West, influenza-like illnesses are trending in the East, and particularly in the Northeast, according to the latest Walgreens Flu Index released Wednesday.
Week to week, there was little change in the flu incidence heat map issued by Walgreens, though Tennessee moved from red, indicating a high level of flu activity, to orange. Meanwhile, Maine moved from a “green” status, suggesting fewer incidents of flu, to orange.
For the week ending Feb. 17, the top 10 designated market areas experiencing flu activity gains were:
- Lincoln & Hastings-Kearney, Neb.;
- Memphis, Tenn.;
- Salisbury, Md.;
- Nashville, Tenn.;
- Paducah, Ky.-Cape Girardeau, Mo.-Harrisburg, Ill.;
- Youngstown, Ohio;
- Lexington, Ky.; and
- Traverse City-Cadillac, Mich.
Overall, the top 10 DMAs with flu incidence for that week were:
- Oklahoma City;
- Dallas-Ft. Worth, Texas;
- Little Rock-Pine Bluff, Ark.;
- El Paso, Texas (Las Cruces, N.M.);
- Nashville, Tenn.;
- Waco-Temple-Bryan, Texas;
- Greensboro-High Point-Winston Salem, N.C.;
- Shreveport, La.;
- Lincoln & Hastings-Kearney, Neb.; and
- Tyler-Longview (Lufkin & Nacogdoches), Texas.
The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. The Flu Index provides insight by showing which cities or metropolitan areas are experiencing the most incidences of influenza each week based on Index methodology. The data does not measure actual levels or severity of flu activity.
The Walgreens Flu Index is compiled using weekly retail prescription data for antiviral medications used to treat influenza across Walgreens and Duane Reade locations nationwide, including Walgreens locations in Puerto Rico. The data is analyzed at state and geographic market levels to measure absolute impact and incremental change of antiviral medications on a per store average basis, and does not include markets in which Walgreens has fewer than 10 retail locations.
Vitalah names new president
Vitalah on Tuesday named Tom Tierney president. Tierney has an extensive sales background in a wide range of business categories and channels.
“We are very proud to have Tom join our executive team. His prominent business background and adaptable leadership style has generated thriving enterprises across multiple retail channels and we are excited to start implementing his strategic plans into our organization,” Lisa Lent, Vitalah CEO, said.
In his most recent endeavor at Amazing Grass, Tierney was recruited to join the entrepreneurial business at its infancy and organized the launch of an organic supplement product line in the natural product channel, e-tail channel and crossover FDM retailers. Responsible for managing direct sales representatives, brokers and international distributors, his leadership role focused on establishing strategic retail partnerships, building sales infrastructure and recruiting and managing a high performance sales team. Amazing Grass was successfully acquired by Glanbia in January 2017.
Now equipped with more than 30 years of experience, Tierney has joined the Oxylent team with high expectations and sales goals. “For the past 9 years, the [Oxylent] brand has continuously received multiple awards and recognition for their superior quality and formulations. Now that is a reputation I can proudly stand behind,” Tierney said. “I’m truly impressed by the owner’s immense passion and determination for the brand as well as a strong team of individuals who possess the qualities necessary to create a successful operation. I’m looking forward to being a part of a team of outstanding individuals and supporting the growth of Oxylent.”
Vitalah recently announced the introduction of four new Oxylent capsule formulas for the 2018 Natural Products Expo West Trade Show March 9th – 11th at the Convention Center located in Anaheim, California.